Characterization of an antiserum against human myeloma cells.
D000042:Absorption; D000818:Animals; D000912:Antibodies, Neoplasm; D000918:Antibody Specificity; D001798:Blood Proteins / Q000276:immunology; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D002460:Cell Line; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007070:Immunoglobulin A; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007146:Immunoglobulin lambda-Chains; D008214:Lymphocytes / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology
D000912:Antibodies, Neoplasm; D001798:Blood Proteins; D007106:Immune Sera; D007070:Immunoglobulin A; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007146:Immunoglobulin lambda-Chains